Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Tops Q4 EPS by 36c

March 1, 2022 4:26 PM EST

Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 EPS of ($0.77), $0.36 better than the analyst estimate of ($1.13). Revenue for the quarter came in at $201.5 million versus the consensus estimate of $198.61 million.

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.

... More